logo-loader

Actinium Pharmaceuticals Inc

Market:
NYSE
Market Cap:
$41.72 m
Price
0.25 USD
Change
-0.24%
52 weeks high
0.69
52 weeks low
0.19

In brief

Actinium is a leading biotechnology company developing targeted radioimmunotherapies for the treatment of cancer patients with unmet needs.